Keep your temper: how to avoid heat accumulation in haemodialysis.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to D Schneditz.
Explore the source record for details and available documents.
BACKGROUND: The influence of potassium (K) removal on dialysis efficiency as measured by urea elimination is not clear. In this prospective, randomized, cross-over study we investigated the magnitude of K removal and its effect on urea (u) elimination during high-flux haemodialysis (HD). METHODS: Twelve stable, non-diabetic HD patients were investigated during three one-week standardized HD periods (1.8 m(2) high-flux polysulphone dialyser, treatment time 240 min, Qb = 300 ml/min, Qd = 500 ml/min, dialysate without glucose, bicarbonate 40 mmol/l), using dialysates containing 0 (0K), 1 (1K), and 2 (2K) mmol/l of K. Mass removal of K (M(K)) and u (M(U)) were measured during the mid-week treatment by partial dialysate collection. Urea reduction rate (URR) and Kt/V were determined. RESULTS: 0K, 1K and 2K treatments were perfectly comparable. Plasma K (PK) continuously declined reaching stable concentrations after 180 min. While 0K dialysate removed 117.1 mmol, 80.2 and 63.3 mmol (P < 0.001) were removed by 1K and 2K baths respectively. M(U) was not influenced by M(K) (r = 0.22) and amounted to 491.1 (0K), 508.6 (1K), and 506.2 (2K) mmol (NS) respectively. Accordingly, urea clearance, URR and Kt/V were constant during 0K, 1K and 2K treatments. CONCLUSIONS: Potassium-free dialysate significantly enhances potassium elimination. Potassium removal has no influence on urea elimination. High potassium removal, when needed, does not impair dialysis efficiency as measured by urea kinetics in high-flux, glucose-free, 40 mmol/l bicarbonate HD.
True access recirculation (AR) measured by ultrasound dilution technique is usually absent in well-working shunts. It occurs with low access flows (Qa). High access flow rates are assumed to prevent AR. Two major exceptions to these rules are known: presence of intra-access strictures and inadvertently reversed blood lines. We present an additional exception in which true access recirculation occurred in a native arteriovenous (AV) fistula with correct placement of bloodlines. Surprisingly, access blood flow exceeded pump blood flow (Qb) almost threefold. The situation was clarified by a magnetic resonance angiogram showing a collateral forming a functional loop. This loop led to true access recirculation in one branch, although overall blood flow through both branches appeared to be adequate. The different findings in this shunt over time give insight into the often complex pathophysiology of native fistulae. This case proves that seemingly adequate access flow does not necessarily prevent access recirculation in native AV fistulae. We suggest monitoring both access flow and recirculation in hemodialysis accesses on a regular basis.
UNLABELLED: Estimation of body fluid changes during peritoneal dialysis by segmental bioimpedance analysis. BACKGROUND: Commonly used bioimpedance analysis (BIA) is insensitive to changes in peritoneal fluid volume. The purpose of this study was to show, to our knowledge for the first time, that a new segmental approach accurately measures extracellular fluid changes during peritoneal dialysis (PD). METHODS: Fourteen stable PD patients were studied during a standard exchange with fluids of known conductivity. Bioimpedance was continuously measured in the arm, trunk, and leg and from wrist to ankle. Volume changes were calculated using both a newly developed sum of segmental BIA (SBIA) and current wrist-to-ankle BIA (WBIA) and were compared with actual volume changes measured gravimetrically. RESULTS: When 2.19 +/- 0.48 L were removed from the peritoneal cavity during draining, 95.2 +/- 13.8% of this volume was detected by SBIA compared with only 12.5 +/- 24. 3% detected by WBIA. When 2.11 +/- 0.20 L of fresh dialysate was infused into the peritoneal cavity during filling, 91.1 +/- 19.6% of this volume was detected by SBIA compared with only 8.8 +/- 21.1% detected by WBIA. CONCLUSION: The good agreement between measured and calculated data using SBIA was due to: (a) improved placement of electrodes, (b) estimation of trunk extracellular volume based on a new algorithm, and (c) consideration of changes in dialysate conductivity. Correct estimation of fluid volume in the trunk is a prerequisite for applications in which direct analysis of fluid changes cannot be performed such as with peritoneal equilibration tests and continuous flow PD.
The increase in patient temperature during hemodialysis is explained by hemodynamic compensation during ultrafiltration and hypovolemia that leads to peripheral vasoconstriction and reduced heat losses. We analyzed 51 stable high-efficiency hemodialysis treatments in 27 patients during isothermic dialysis in which body temperature was maintained at a constant level (+/-0.1 degrees C) using the temperature-control option of the Blood Temperature Monitor (BTM; Fresenius Medical Care, Bad Homburg, Germany). Hemodialysis was delivered using ultrapure water (limulus amebocyte lysate test < 0. 06 endotoxin units/mL) at mean blood flows of 410 +/- 40 mL/min. During treatments lasting 178 +/- 23 minutes, 4.8% +/- 1.4% of postdialysis body weight (W%) and 9.5% +/- 2.5% of postdialysis body water were removed using mean ultrafiltration rates of 1.1 +/- 0.3 L/h. Dialysate temperatures significantly decreased from 35.9 degrees C +/- 0.3 degrees C to 35.6 degrees C +/- 0.6 degrees C during hemodialysis. During these treatments, 187 +/- 69 kJ of thermal energy were removed from the patients through the extracorporeal circulation using cool dialysate. Extracorporeal heat flow was 17 +/- 6 W. Energy expenditure (H) estimated from anthropometric data was 65 +/- 12 W. Thus, 28% +/- 10% of estimated energy expenditure (H%) was removed during isothermic dialysis. A highly significant correlation was observed between H% and W% (H% = -5.6 * W%; r(2) = 0.91; P < 0.0001). This result is in support of the volume hypothesis of intradialytic heat accumulation and provides a rule of thumb to estimate extracorporeal cooling requirements for isothermic dialysis. Approximately 6% of H must be removed through the extracorporeal circulation for each percent of ultrafiltration-induced body-weight change. The importance of body temperature control during hemodialysis increases with increased ultrafiltration requirements.
BACKGROUND/AIM: Recirculation measured by thermodilution includes effects caused by access and cardiopulmonary recirculation. The aims of this study were to illustrate the accuracy of thermodilution in measurement of hemodialysis recirculation and also to identify a sensitive and specific threshold to detect access recirculation. METHODS: 110 studies were performed in 19 patients. Recirculation obtained directly by the blood temperature monitor (BTM) was compared to that calculated from access blood flow, pump blood flow, and cardiac output determined by ultrasound dilution using the hemodialysis monitor (HDM). RESULTS: A highly significant linear correlation was obtained between repeated BTM recirculation measurements (R(BTM, 2) = 0.99.R(BTM, 1) - 0.22%, r(2) = 0.99). There were no significant differences between repeated BTM recirculation measurements with correct placement (11.4+/-7.1 vs. 10.9+/-7.4%, p = NS) or reversed placement (30.0+/-15.6 vs. 30.2 +/-15.9%, p = NS) of blood lines. A strong linear relationship was obtained between the recirculation determined by thermodilution and the recirculation calculated from HDM measurements (R(calc) = 0.98. R(BTM) - 1.49%, r(2) = 0.95). The mean recirculation obtained by BTM was not significantly different from the recirculation calculated by HDM with correct placement (9.5+/- 2.2 vs. 8.6+/-2.5%, p = NS) or with reversed placement (25.4+/-7.8 vs. 23.8+/-7.7%, p = NS) of blood lines. When a recirculation greater than 15% measured by the BTM was considered as the threshold at which true access recirculation occurred, sensitivity and specificity of the thermodilution method to detect access recirculation were 93 and 98%, respectively. CONCLUSIONS: Recirculation measurements made by the BTM are accurate and precise. Even though BTM thermodilution includes effects of cardiopulmonary recirculation, so that low levels of access recirculation might not be detected, a BTM recirculation >15% represents a highly significant access recirculation.
AIMS: Low access flow and the diagnosis of high degrees of venous stenosis have been recommended as indications for prophylactic angioplasty. However, recent studies have shown that prophylactic angioplasty for > 50% stenosis did not prolong graft patency, and that a single flow measurement may not accurately predict graft failure. In this study we compared the value of monthly measurement of access flow and of the maximal degree of stenosis in the detection of graft failure over a three-month period. METHODS: Thirty-nine hemodialysis patients with polytetrafluoroethylene (PTFE) grafts were evaluated by Doppler ultrasound at monthly intervals for three months. Graft failures were defined as thrombosis, or surgical and angioplastic revisions required because of the presence of access recirculation, and patients with graft failure were followed within the subsequent one-month periods of observation. RESULTS: Twelve graft failures occurred during the three-month period of observation. The risk for subsequent graft failure significantly increased at flows < 300 ml/min. Nine (20%) graft failures occurred with stenoses of 30 to 50%, and three (13%) with stenoses of> 50%. The grafts that failed in the second and the third study months had a 25.8% (380 +/- 62 vs. 287 +/- 190 ml/min, p < 0.05) and a 36.5% (393 +/- 142 vs. 226 +/- 41 ml/min, p < 0.05) decrease in access flow, respectively. There was no significant change in access flow for the grafts patent throughout the study (911 +/- 333, 794 +/- 302, and 919 +/383 ml/min, p = ns). No significant increases in maximal stenosis were found for the grafts that failed in the second month (44 +/- 6.1 vs. 48 +/- 15%, p = ns) and the third month (48 +/- 9 vs. 51 +/- 16%, p = ns). There were no significant changes in the maximum stenosis for the grafts patent throughout the three-month study periods (37 +/- 15,43 +/- 11, and 44 +/- 15%, p = ns). CONCLUSIONS: Access flow is a more sensitive predictor of graft failure than stenosis. Examination of trend in decline of access flow is a more powerful indicator to detect graft dysfunction than an individual single flow value.
BACKGROUND: Bioimpedance, a noninvasive technique to analyze body composition, has attracted interest in determining body hydration in hemodialysis patients. However, the so-called whole-body (wrist-to-ankle) bioimpedance analysis (WBIA) is sensitive to changes in regional fluid distribution and tends to underestimate fluid changes during ultrafiltration in hemodialysis patients. The aim of this study was to show that volume changes calculated from a new approach, that is, segmental bioimpedance analysis (SBIA), are not affected by changes in body position. METHODS: Ten male patients (age 44 +/- 8 years, target weight 70.8 +/- 10 kg) were studied during their regular hemodialysis treatment while maintaining either a sitting or a supine body position throughout the study. Extracellular volume was calculated from extracellular resistance obtained from bioimpedance data measured for a range of frequencies (5 to 500 kHz) using the Xitron BIS4000B analyzer. Wrist-to-ankle measurements were compared with segmental arm, trunk, and leg measurements. RESULTS: Changes in extracellular volume estimated from wrist-to-ankle measurements only reached 80 +/- 13% and 65 +/- 17% of the actual change in body mass during sitting and supine dialysis treatments, respectively. However, when segmental measurements were analyzed, the calculated change in extracellular volume was 101 +/- 6% and 100 +/- 3% of the actual change in body mass during the sitting and supine treatments, respectively. CONCLUSIONS: SBIA properly identifies regional fluid changes and provides an appropriate measure of fluid changes caused by ultrafiltration and hemodialysis. The volume estimation based on the sum of segmental bioimpedance measurements is independent of body position, which is a prerequisite for applications in everyday practice.
BACKGROUND: Recirculation (R) and access blood flow (Qac) measurements are considered useful indicators of adequate delivery of haemodialysis. It was the purpose of this study to compare measurements of R and Qac obtained by two different techniques which are based on the same principle of indicator dilution, but which differ because of the characteristics of the injection and detection of the different indicators used. METHODS: Recirculation measured by a thermal dilution technique using temperature sensors (BTM, Fresenius Medical Care) was compared with recirculation measured by a validated saline dilution technique using ultrasonic transducers placed on arterial and venous segments of the extracorporeal circulation (HDM, Transonic Systems, Inc.). Calculated access flows were compared by Bland Altman analysis. Data are given as mean +/- SD. RESULTS: A total of 104 measurements obtained in 52 treatments (17 patients, 18 accesses) were compared. Recirculation measured with correct placement of blood lines and corrected for the effect of cardiopulmonary recirculation using the 'double recirculation technique' was -0.02 +/- 0.14% by the BTM technique and not different from the 0% measured by the HDM technique. Recirculation measured with reversed placement of blood lines and corrected for the effect of cardiopulmonary recirculation was 19.66 +/- 10.77% measured by the BTM technique compared with 20.87 +/- 11.64% measured by the HDM technique. The difference between techniques was small (-1.21 +/- 2.44%) albeit significant. Access flow calculated from BTM recirculation was 1328 +/- 627 ml/min compared with 1390 +/- 657 ml/min calculated by the HDM technique. There was no bias between techniques. CONCLUSION: BTM thermodilution yields results which are consistent with the HDM ultrasound dilution technique with regard to both recirculation and access flow measurement.
BACKGROUND: Access blood flow (Qac) is considered a useful indicator in the surveillance of haemodialysis access function. However, changes in Qac may be due to changes in blood pressure and/or to changes in access resistance (AR). METHODS: Weekly readings of Qac, cardiac output, and arterial blood pressure measured early and late during haemodialysis were obtained in 11 patients for a period of 3 weeks. Qac was determined from thermodilution of extracorporeal blood returning to the patient with reversed placement of blood lines and by measurement of arterial and venous blood temperatures in the extracorporeal circulation. Data are given as mean +/- SE. RESULTS: Qac dropped as mean arterial pressure (MAP) and total peripheral resistance (TPR) decreased, but increased when MAP and TPR increased. Linear regressions between the change in access flow and the change in MAP (deltaQac%=0.80*deltaMAP%-1.6, r2=0.39), and the change in TPR (deltaQac%= 0.54*deltaTPR%-9.2, r2=0.35) respectively, were significant (P<0.001). Whereas Qac significantly decreased (-8.4+/-3.3%, P<0.01) during the same treatment, AR remained unchanged (4.7+/-3.2%; P=NS). AR for all studies was 16.5+/-1.0 peripheral resistance units (1 PRU=2.226 kPa min l(-1)). There was a trend for resistance to increase (5.1+/-2.6%, P=NS) and for flow to decrease (-6.1+/-2.3%, P=NS) during the 3 weeks of the study. CONCLUSION: Qac measured during haemodialysis is variable and depends on haemodynamics, but AR is constant. AR is related to the physical structure of the peripheral access. Because of its intradialytic stability AR may be better suited as an indicator of access function.
BACKGROUND: Hypotension complicates approximately 30% of all dialysis treatments. Although the genesis of hypotension is multifactorial, hypovolaemia is thought to play a major role as a direct result of decreased blood volume, particularly during ultrafiltration. The described blood volume monitor enables blood volume to be measured continuously by a non-invasive technique. METHODS: The blood volume monitor is based on the principle that the total protein concentration, the sum of haemoglobin and plasma proteins in the vascular space, changes during ultrafiltration. Changes of total protein concentration are determined from the velocity of sound waves in blood, measured using a cuvette in the extracorporeal circuit designed for this purpose. The precision of the blood volume monitor was evaluated in 180 dialysis treatments in 49 patients. The relative blood volume obtained by the monitor was compared with a standard reference method involving calculation of relative blood volume from serial measurements of haemoglobin. RESULTS: A very good agreement between the two methods was achieved (SD = 1.70%, r > 0.96). The results showed no sensitivity to changes in serum sodium concentration (range 130-145 mmol). The 'noise' introduced in the blood volume signal was low (< or = 0.2%, sampling rate 10 s) allowing subtle blood volume changes to be detected with high resolution. In addition the device enabled the measurement of haematocrit (Hct) and haemoglobin (Hb) to be made since this is the largest blood component determining total protein concentration. A comparison with the centrifuge method revealed an accuracy of +/-2.9 Hct-%, and a comparison with the photometer an accuracy of +/-0.8 g Hb/dl. CONCLUSION: In summary the blood volume monitor allows precise and reliable measurement of relative blood volume. It provides the instrumentation essential for feedback control of relative blood volume during dialysis.
Explore the source record for details and available documents.
Extracellular volume (ECV) of arms, trunk, and legs determined from segmental bioimpedance data in 11 healthy men (31.6 +/- 7 yr) obtained at the end of a 30-min equilibration phase in the supine body position was compared with ECV determined from whole body measurements (ECVWB). ECV was calculated from extracellular resistance (RECV) identified from the bioimpedance spectrum for a range of 10 frequencies. Whole body RECV (527.6 +/- 55.6 Omega) was equal to the sum of RECV in the arms, trunk, and legs (241.6 +/- 36. 3, 49.2 +/- 5.1, and 236.3 +/- 25.5 Omega, respectively). The sum of equilibrated ECV in arms (1.31 +/- 0.25 liters), trunk (10.08 +/- 1.65 liters), and legs (2.80 +/- 0.82 liters) was smaller than ECVWB (20.90 +/- 2.59 liters). In six subjects who changed from a standing to a supine body position, ECV decreased in arms (-2.59 +/- 2.51%, P = NS) and legs (-10.96 +/- 3.02%, P < 0.05) but increased in the trunk (+4.2 +/- 3.2%, P < 0.05). ECVWB also decreased (-4.98 +/- 1. 41%, P < 0.05). However, the sum of segmental extracellular volumes remained unchanged (-0.06 +/- 0.07%, P = NS). The sum of segmental ECVs is not sensitive to changes in body position, which otherwise interferes with the estimation of ECV in bioimpedance analysis when ECVWB is used.
Considerable amounts of heat may be lost or gained through the extracorporeal circuit during hemodialysis and influence the hemodynamic stability of the dialysis patient. The effects of two levels of extracorporeal heat flux (Jtherm in W) on blood pressures and ultrafiltration-induced blood volume changes were studied in eight patients on conventional hemodialysis. Treatments were controlled automatically for mild to medium Jtherm of either -13.4 +/- 3.3 W (group A) or -30.2 +/- 3.7 W (group B) (1 W = 1 J/s = 3.6 kJ/h = 0.239 cal/s = 0.86 kcal/h) and repeated once. Values are given as mean +/- SD. With low blood flows (Qb = 251 +/- 21 ml/min), dialysate temperatures were automatically set at 37.3 +/- 0.3 degrees C (group A) and 35.3 +/- 0.2 degrees C (group B) for the two levels of Jtherm, respectively. Arterial blood temperatures increased by 0.4 +/- 0.4 degree C with mild extracorporeal cooling (group A), whereas arterial blood temperatures slightly decreased by -0.1 +/- 0.4 degree C in the group with medium negative heat flux (group B) (P < 0.01). Blood pressures tended to drop in the warm dialysate group and to remain unchanged in the cool dialysate group (P = NS). Relative blood volume changes calculated from on-line ultrasonic blood measurements were significantly larger with cool (-12.8 +/- 8.3 vol%) than with warm (-7.2 +/- 5.5 vol%, P < 0.05) dialysate, indicating reduced fluid removal from peripheral body compartments during cool hemodialysis ultrafiltration. Despite the larger reduction in intravascular volume, intradialytic hemodynamic stability was maintained with extracorporeal cooling and cool dialysate prescription.
The effect of vascular access recirculation (AR) on the modeled urea distribution volume (V) is not straightforward. When blood is sampled properly so that it is not admixed with recirculated blood, AR will cause an unexplained increase in V in cases in which AR is present throughout the dialysis session (when AR is limited to the terminal portion of a dialysis session it will cause little or no change in the modeled V). On the other hand, when blood is sampled from the arterial line after simply stopping the pump, postdialysis blood urea nitrogen (BUN) represents arterial line BUN and does not always reflect the BUN in the patient's blood. Under these conditions, when AR is present throughout the dialysis session the modeled V usually shows an unexplained decrease, but V may be unchanged, depending on the urea reduction ratio (URR). We performed a mathematical analysis to predict when V would be decreased and when it would be unchanged when the postdialysis BUN is contaminated with admixed blood. The analysis revealed that when AR is present uniformly throughout the dialysis session, the modeled V should be underestimated when the URR is < or = O.70. When the URR is greater than 0.70, even severe degrees of AR may not be reflected by a change in V. When AR is limited to the terminal part of the dialysis session or when AR increases during the dialysis session, and when V is based on admixed postdialysis blood, underestimation of V will occur in almost all circumstances. In a cross-sectional comparison of modeled to anthropometric volume ratios in eight patients with severe AR and in 11 controls, and in sequential modeling studies in a single patient in whom severe AR developed gradually over time, the volume ratio was low in most, but not all instances when modeled V was based on an admixed postdialysis BUN sample.
The regional blood flow model predicts that urea sequestration occurs in organs rather than cells, and that post-dialysis urea rebound is a function of both cardiac index (CI) and regional blood flow distribution to muscle. We measured cardiac output (CO) in 100 randomly selected dialysis patients using bioelectric impedance three times during a single dialysis. Mean CO was 5.8 +/- 2.1 liter/min and CI averaged 3.1 +/- 1.1 liter/min/M2. CI was negatively correlated with age (r = -0.48, P < 0.01). CI was strongly affected by vasodilator ingestion (yes, N = 36, CI = 3.5 +/- 1.2; no, N = 64, CI = 2.88 +/- 0.92, P < 0.006). CI was not associated with systolic, diastolic, or mean blood pressures, nor with Hct, although very few severely anemic patients were in the cohort. Repeat intra-dialytic CO measurements two to three months later in 15 patients with low CI (2.59 +/- 0.59 liter/min/M2) and in 13 patients with high CI (5.00 +/- 0.9, P < 0.001) during a urea kinetic modeling session including 30 minutes post-dialysis rebound, sampling showed highly reproducible values for CO, with a mean absolute value % difference between CO values measured several months apart of 9.0 +/- 17%, r = 0.92. Urea rebound expressed as the difference (delta Kt/V30) between equilibrated and single-pool Kt/V was lower in the high CI group (-0.099 +/- 0.07) than in the low CI group (-0.16 +/- 0.06, P = 0.026), and delta KT/V30 as well as delta Kt/V30 divided by K/V correlated with CI (r = 0.48 and 0.48, respectively, P < 0.01). The RBF model was used to compute a group mean predicted delta Kt/V30 for the low CI and high CI groups based on measured group mean values for CI and K/V. The predicted delta Kt/V30 values for the high CI group (-0.097) and the low CI group (-0.183) agreed closely with measured values. RBF modeled values of CO (7.46 +/- 2.96 liter/min) were not significantly different from impedance-derived CO (6.93 +/- 2.70 liter/min), and the two CO measures correlated significantly (r = 0.63, P = 0.0003). The results provide support for the regional blood flow model of urea kinetics.
Explore the source record for details and available documents.
Mathematical models that simulate the exchange of solute between multiple body compartments have been used to study the distribution, elimination, and transport of urea, water, electrolytes, and other substances in the dialysis patient. Within a compartment, such substances are assumed to be uniformly distributed while exchange between compartments or with the environment may occur in a number of different ways. Diffusion in response to concentration gradients between, for example, intracellular and extracellular spaces, and convection due to blood flow have been identified as the most important transport mechanisms. Any system with more than one compartment may develop nonuniform solute distribution or solute disequilibrium between compartments. The minimum number of compartments required to model a kinetic process such as urea removal during hemodialysis depends on the accuracy and temporal resolution required, with higher resolution calling for more compartments. A two-compartment model is adequate for most clinical purposes. The physiological meaning or anatomic counterparts of the mathematical compartments remain uncertain as both flow and diffusion transport mechanisms contribute to the disequilibrium. Processes such as access and cardiopulmonary recirculation may be represented as additional compartments with small distribution volumes and high mass transport rates. Failure to recognize the effect of multiple compartments will result in an inaccurate measurement of dialysis dose and an inadequate hemodialysis prescription with a predictably poor clinical outcome. Allowance for compartment effects is particularly important in patients receiving treatment with a high ratio of dialyzer clearance to total body water, now commonly encountered during short-time, high-efficiency dialysis.